A Simple Glutathione-Responsive Turn-On Theranostic Nanoparticle for Dual-Modal Imaging and Chemo-Photothermal Combination Therapy
Authors:
- 23 July 2019
- journal article
- letter
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 19 (8) , 5806-5817
Abstract
Constructing a tumor microenvironment stimuli activatable theranostic nanoparticle with simple components and preparation procedures for multimodality imaging and therapy remains a major challenge for current theranostic systems. Here we report a novel and simple glutathione (GSH)-responsive turn-on theranostic nanoparticle for dual-modal imaging and combination therapy. The theranostic nanoparticle, DHP, consisting of a disulfide-bond-linked hydroxyethyl starch paclitaxel conjugate (HES-SS-PTX) and a near-infrared (NIR) cyanine fluorophore DiR, is prepared with a simple one-step dialysis method. As DiR is encapsulated within the hydrophobic core formed by HES-SS-PTX, the fluorescence of DiR is quenched by the aggregation-caused quenching (ACQ) effect. Nonetheless, once DHP is internalized by cancer cells, the disulfide bond of HES-SS-PTX can be cleaved by intracellular GSH, leading to the synchronized release of conjugated PTX and loaded DiR. The released PTX could exert its therapeutic effect, while DiR could adsorb onto nearby endosome/lysosome membranes and regain its fluorescence. Thus, DHP could monitor the release and therapeutic effect of PTX through the fluorescence recovery of DiR. Remarkably, DHP can also be used as an in vivo probe for both fluorescent and photoacoustic imaging and at the same time achieves potent antitumor efficacy through chemo-photothermal combination therapy. This study provides novel insights into designing clinically translatable turn-on theranostic systems.Keywords
Funding Information
- Ministry of Science and Technology of the People's Republic of China (2018YFA0208900)
- National Natural Science Foundation of China (31700867, 81627901)
- PCSIRT (3004170130)
- National Basic Research Program of China (2015CB931802)
- Program for HUST Academic Frontier Youth Team (2018QYTD01)
- Scientific Research Foundation of Huazhong University of Science and Technology (3004170130)
This publication has 36 references indexed in Scilit:
- Polymer–drug conjugate therapeutics: advances, insights and prospectsNature Reviews Drug Discovery, 2018
- Precise nanomedicine for intelligent therapy of cancerScience China Chemistry, 2018
- Fluorogenic reaction-based prodrug conjugates as targeted cancer theranosticsChemical Society Reviews, 2017
- Self-assembling prodrugsChemical Society Reviews, 2017
- Cancer‐Associated, Stimuli‐Driven, Turn on Theranostics for Multimodality Imaging and TherapyAdvanced Materials, 2017
- Leveraging Physiology for Precision Drug DeliveryPhysiological Reviews, 2017
- Dual-channel NIR activatable theranostic prodrug for in vivo spatiotemporal tracking thiol-triggered chemotherapyChemical Science, 2016
- Disulfide-Based Multifunctional Conjugates for Targeted Theranostic Drug DeliveryAccounts of Chemical Research, 2015
- In Vivo and in Situ Tracking Cancer Chemotherapy by Highly Photostable NIR Fluorescent Theranostic ProdrugJournal of the American Chemical Society, 2014
- Disulfide-Cleavage-Triggered Chemosensors and Their Biological ApplicationsChemical Reviews, 2013